1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Differences in absolute metabolite concentrations (and SE, in mM in aqueous fraction) in NAWM between patients with MS (and normal MRI scan of the brain) and control subjects
Absolute Metabolite Concentration Patients, mM Control Subjects, mM P (Mann-Whitney) P (2-way ANOVA) Cho Mean 2.16 2.38 <.001 <.001 SE 0.04 0.05 Cr Mean 7.03 7.35 .029 .013 SE 0.07 0.10 m-Ins Mean 6.38 6.18 n.s. n.s. SE 0.15 0.13 NAA Mean 10.26 10.96 .003 .004 SE 0.16 0.19 tNA Mean 13.54 14.62 .002 <.001 SE 0.21 0.26
Note:—Cho indicates choline; Cr, creatine; m-Ins, myo-inositol; NAA, N-acetylaspartate; tNA, total N-acetyl compounds including NAA and NAAG; n.s., not significant; MS, multiple sclerosis; NAWM, normal-appearing white matter.